Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance.
about
A survey of computational tools for downstream analysis of proteomic and other omic datasetsA protein deep sequencing evaluation of metastatic melanoma tissuesA multiplexed, targeted mass spectrometry assay of the S100 protein family uncovers the isoform-specific expression in thyroid tumours.The association between S100A13 and HMGA1 in the modulation of thyroid cancer proliferation and invasionProteomic Findings in Melanoma.Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells.
P2860
Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Proteomics analysis of melanom ...... n and chemotherapy resistance.
@ast
Proteomics analysis of melanom ...... n and chemotherapy resistance.
@en
type
label
Proteomics analysis of melanom ...... n and chemotherapy resistance.
@ast
Proteomics analysis of melanom ...... n and chemotherapy resistance.
@en
prefLabel
Proteomics analysis of melanom ...... n and chemotherapy resistance.
@ast
Proteomics analysis of melanom ...... n and chemotherapy resistance.
@en
P2093
P2860
P50
P356
P1476
Proteomics analysis of melanom ...... on and chemotherapy resistance
@en
P2093
M Frostvik Stolt
S Egyházi Brage
P2860
P2888
P304
P356
10.1038/BJC.2014.169
P407
P577
2014-04-10T00:00:00Z
P5875
P6179
1005543724